WBCPI 100.32 0.0% BHP 45.37 0.688% CBA 134.61 0.313% RIO 126.04 0.0635% CSL 288.61 0.554% NAB 37.0 0.0541% WBC 30.71 -1.2858% ANZ 30.08 -0.0996% NEM 78.24 0.0384% MQG 226.55 0.1724% WES 69.03 0.0725% GMG 37.8 1.5583% FMG 19.98 -0.7944% SQ2 94.0 -1.3848% RMD 34.76 -0.4582% WDS 26.06 0.5789% WTC 134.6 -0.3553% TLS 3.88 -0.5128% TCL 13.19 0.7639% WOW 33.01 0.1213%
Last update at 2024-10-03T06:11:00Z
Basic Materials Roundup: Market Talk
Mon 22 Jan 24, 11:19 AMDo Its Financials Have Any Role To Play In Driving Nufarm Limited's (ASX:NUF) Stock Up Recently?
Fri 19 Jan 24, 11:54 PMNufarm (ASX:NUF) Is Reducing Its Dividend To A$0.05
Sat 18 Nov 23, 10:37 PMHere's What We Like About Nufarm's (ASX:NUF) Upcoming Dividend
Fri 17 Nov 23, 08:28 PMInvestors Could Be Concerned With Nufarm's (ASX:NUF) Returns On Capital
Sun 12 Nov 23, 12:06 AMNufarm Limited (ASX:NUF) is a favorite amongst institutional investors who own 82%
Sat 21 Oct 23, 11:01 PMInvestors in Nufarm (ASX:NUF) have unfortunately lost 18% over the last five years
Wed 04 Oct 23, 08:36 PMEstimating The Fair Value Of Nufarm Limited (ASX:NUF)
Thu 13 Jul 23, 01:01 AMNorway Approves Aquaterra® Omega-3 Oil for use in Aquafeed
Thu 29 Jun 23, 09:08 PMBreakdown | 2023-07-31 | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-07-31 | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 |
Income before tax | 154.83M | 128.10M | 95.69M | -310.50600M | 80.95M |
Minority interest | - | - | - | 246.93M | 343.93M |
Net income | 111.14M | 107.44M | 65.13M | -456.07900M | 38.31M |
Selling general administrative | 230.56M | 198.81M | 172.89M | 446.23M | 223.77M |
Selling and marketing expenses | 515.59M | 523.34M | 477.62M | 486.36M | 561.15M |
Gross profit | 1026.37M | 972.59M | 834.71M | 734.73M | 1013.28M |
Reconciled depreciation | 188.37M | 213.68M | 208.01M | 208.03M | 171.71M |
Ebit | 236.26M | 203.16M | 151.17M | -218.73100M | 196.19M |
Ebitda | 424.63M | 416.84M | 359.18M | -10.70000M | 367.90M |
Depreciation and amortization | 188.37M | 213.68M | 208.01M | 208.03M | 171.71M |
Non operating income net other | - | - | - | - | - |
Operating income | 236.26M | 203.16M | 151.17M | -428.54200M | 15.52M |
Other operating expenses | 3433.44M | 3787.32M | 3276.13M | 3275.92M | 3742.07M |
Interest expense | 81.43M | 75.06M | 55.49M | 91.78M | 115.24M |
Tax provision | 43.69M | 20.66M | 30.56M | 51.91M | 31.93M |
Interest income | 5.38M | 82.56M | 1.62M | 99.60M | 66.24M |
Net interest income | -84.57600M | -80.18400M | -61.29000M | -88.37000M | -105.19100M |
Extraordinary items | - | - | - | -93.66700M | 49.45M |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | 43.69M | 20.66M | 30.56M | 51.91M | 42.64M |
Total revenue | 3480.61M | 3772.97M | 3215.65M | 2847.38M | 3757.59M |
Total operating expenses | 979.20M | 986.94M | 895.18M | 1163.27M | 997.76M |
Cost of revenue | 2454.24M | 2800.39M | 2380.95M | 2112.65M | 2744.31M |
Total other income expense net | 3.85M | -75.05500M | -55.48600M | 6.20M | 0.96M |
Discontinued operations | - | - | - | -93.66700M | 49.45M |
Net income from continuing ops | 111.14M | 107.44M | 65.13M | -362.41200M | 38.31M |
Net income applicable to common shares | - | 99.92M | 57.73M | -469.71500M | 27.35M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2023-07-31 | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-07-31 | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 |
Total assets | 4625.07M | 4659.10M | 4372.06M | 4535.17M | 5676.52M |
Intangible assets | 1006.52M | 977.06M | 1036.46M | 1130.55M | 1352.52M |
Earning assets | - | - | - | - | - |
Other current assets | 75.41M | 74.70M | 77.81M | 52.10M | 97.50M |
Total liab | 2315.18M | 2506.38M | 2250.59M | 2391.55M | 3271.58M |
Total stockholder equity | 2309.89M | 2152.72M | 2121.46M | 2143.62M | 2404.94M |
Deferred long term liab | - | 405.90M | 377.33M | 337.33M | 327.10M |
Other current liab | 151.87M | 190.81M | 135.76M | 179.03M | 168.46M |
Common stock | 1840.61M | 1837.23M | 1835.89M | 1834.93M | 1834.59M |
Capital stock | 1840.61M | 1837.23M | 2082.82M | 1834.93M | 2178.53M |
Retained earnings | 89.34M | 25.81M | -56.34900M | -18.04800M | 475.93M |
Other liab | - | 236.25M | 238.67M | 264.95M | 249.29M |
Good will | 223.73M | 215.72M | 207.37M | 208.47M | 366.51M |
Other assets | - | 164.80M | 521.37M | 473.72M | 642.07M |
Cash | 410.96M | 585.70M | 724.22M | 686.55M | 505.69M |
Cash and equivalents | - | 7.54M | 14.19M | 8.02M | 81.41M |
Total current liabilities | 872.99M | 1607.43M | 1223.43M | 1337.64M | 1771.71M |
Current deferred revenue | - | - | - | - | - |
Net debt | 849.84M | 346.17M | 316.82M | 441.26M | 1247.13M |
Short term debt | 47.76M | 269.17M | 252.54M | 338.86M | 494.99M |
Short long term debt | 29.04M | 250.59M | 234.44M | 320.44M | 494.48M |
Short long term debt total | 1260.80M | 931.87M | 1041.03M | 1127.82M | 1752.82M |
Other stockholder equity | 246.93M | 246.93M | 246.93M | 246.93M | 343.93M |
Property plant equipment | - | 475.33M | 441.37M | 439.64M | 393.58M |
Total current assets | 2574.45M | 2761.10M | 2534.80M | 2617.48M | 3246.50M |
Long term investments | 68.33M | 61.31M | 8.02M | 2.64M | 2.43M |
Net tangible assets | - | 1118.91M | 1008.03M | 895.00M | 661.82M |
Short term investments | - | - | - | 0.00000M | 97.50M |
Net receivables | 624.07M | 498.24M | 756.61M | 946.02M | 1336.59M |
Long term debt | 1087.09M | 539.41M | 663.03M | 662.38M | 1245.49M |
Inventory | 1464.01M | 1602.46M | 976.16M | 932.81M | 1228.24M |
Accounts payable | 673.36M | 1147.45M | 835.14M | 819.74M | 1108.27M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | 133.01M | 42.75M | 94.99M | 79.81M | -249.50800M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | 1834.93M | 1834.59M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 6.44M | 3.78M | 1.43M | 3.09M | 101.98M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 2050.61M | 1898.00M | 1837.25M | 1917.69M | 2430.02M |
Capital lease obligations | 144.68M | 141.86M | 143.56M | 145.00M | 12.85M |
Long term debt total | - | 662.70M | 788.50M | 788.96M | 1257.83M |
Breakdown | 2023-07-31 | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-07-31 | 2022-07-31 | 2021-07-31 | 2020-07-31 | 2019-07-31 |
Investments | -241.73100M | -240.40900M | -4.59200M | 1115.59M | -1.44000M |
Change to liabilities | - | 390.55M | 18.82M | -61.89600M | 52.95M |
Total cashflows from investing activities | - | -240.40900M | -146.29900M | 1115.59M | -173.98000M |
Net borrowings | - | -190.86600M | 30.85M | -651.57700M | 10.36M |
Total cash from financing activities | 185.98M | -264.36600M | 19.18M | -670.68300M | 269.99M |
Change to operating activities | - | 8.85M | 10.52M | -142.08600M | 73.76M |
Net income | 111.14M | 107.44M | 65.13M | -456.07900M | 38.31M |
Change in cash | -174.74500M | -138.51300M | 300.30M | 180.87M | 211.34M |
Begin period cash flow | 585.70M | 724.22M | 423.91M | 505.69M | 294.34M |
End period cash flow | 410.96M | 585.70M | 724.22M | 686.55M | 505.69M |
Total cash from operating activities | -125.62000M | 321.12M | 424.19M | -231.51400M | 98.13M |
Issuance of capital stock | - | - | - | 97.00M | - |
Depreciation | - | 213.68M | 208.01M | 208.03M | 171.71M |
Other cashflows from investing activities | - | -79.49200M | -3.81200M | 1283.64M | 1283.64M |
Dividends paid | -56.45100M | -40.15800M | -10.22900M | -17.13500M | 34.09M |
Change to inventory | - | -684.57200M | 53.91M | -3.02600M | -61.18400M |
Change to account receivables | - | 259.52M | 49.01M | -93.70200M | -194.55200M |
Sale purchase of stock | - | - | - | -97.50000M | 296.01M |
Other cashflows from financing activities | 832.55M | 444.44M | 446.20M | 1698.24M | -2.28800M |
Change to netincome | - | 64.10M | 18.89M | 317.24M | 17.14M |
Capital expenditures | 226.74M | 160.92M | 142.49M | 168.90M | 174.64M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | - | -117.56700M | 45.80M | -501.53300M | -273.63500M |
Stock based compensation | - | - | - | - | - |
Other non cash items | - | -321.11800M | -273.13500M | 248.05M | -210.01800M |
Free cash flow | -352.36300M | 160.20M | 281.70M | -400.41700M | -76.50700M |
Sector: Basic Materials Industry: Agricultural Inputs
Company | Change (AUD) | Price (AUD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
NUF Nufarm Ltd |
-0.04 1.04% | 3.81 | 95.25 | 13.72 | 0.44 | 0.71 | 0.82 | 9.17 |
DNK Danakali Ltd |
- -% | 0.41 | - | - | 1721.13 | 2.36 | 1551.62 | -32.4142 |
HFR Highfield Resources Ltd |
- -% | 0.29 | - | - | 3499.97 | 0.93 | -19.9393 | |
MNB Minbos Resources Ltd |
-0.001 2.13% | 0.05 | - | - | 1000000.00 | 1.43 | 2057.52 | -154.8857 |
TGH Terragen Holdings Ltd |
- -% | 0.03 | - | - | 5.70 | 2.29 | 3.83 | -0.3396 |
Nufarm Limited, together with its subsidiaries, develops, manufactures, and sells crop protection solutions and seed technologies in Europe, the Middle East, Africa, North America, and the Asia Pacific. The company operates through Crop Protection and Seed Technologies segments. The Crop Protection segment solutions include herbicides, insecticides, and fungicides that help growers protect crops against weeds, pests, and diseases. The Seed Technologies segment operates base seeds, bioenergy, omega-3 and seed treatment platforms, as well as sells seeds and oil based products. It also focuses on crops, such as cereals; corn; soybean; pasture, turf, and ornamentals; and trees, nuts, vines, and vegetables. In addition, the company provides seed treatment products for the protection and treatment of damage caused by insects, fungus, and disease. Further, it distributes sunflower, sorghum, and canola seeds. Nufarm Limited was founded in 1916 and is headquartered in Laverton North, Australia.
103-105 Pipe Road, Laverton North, VIC, Australia, 3026
Name | Title | Year Born |
---|---|---|
Mr. Gregory Allan Hunt AICD, AMP Harvard, Grad. Dip., Mgmnt, REBA | MD, CEO & Exec. Director | 1959 |
Mr. Paul Ronald Townsend | Chief Financial Officer | 1966 |
Mr. David Craig Allen | Group Exec. of Supply Chain Operations | NA |
Ms. Rachel Scully | Gen. Mang. of Investor Relations & External Communications | NA |
Ms. Kate Hall B.Sc., L.L.B., L.L.M. | Company Sec. & Group Gen. Counsel | NA |
Mr. John Holding | Group Exec. of People & Performance | NA |
Mr. Brent Zacharias | Group Exec. of Nuseed | NA |
Mr. Rico Toft Christensen | Group Exec. of Portfolio Solutions | 1970 |
Mr. Gregory Allan Hunt AICD, AMP Harvard, Grad. Dip., Mgmnt, REBA | MD, CEO & Executive Director | 1959 |
Mr. Gregory Allan Hunt AICD, AMP Harvard, Grad. Dip., Mgmnt, REBA | MD, CEO & Executive Director | 1959 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.